The Motley Fool on MSN2h
Billionaire Israel Englander Increased His Stake In Eli Lilly During the Third Quarter: Should You?Eli Lilly lost the momentum it had during the first half of the year. However, the company still has plenty of ...
Eli Lilly, Novo Nordisk, and Amgen all look cheap. All of them could experience a massive boost to profits in the years to ...
In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) stands against Jim Cramer’s other stocks. Jim Cramer, the host of Mad Money, recently shared his insights ...
Eli Lilly (NYSE: LLY) sells a broad range of pharmaceuticals treating various diseases, but one portfolio in particular has ...
The pharmaceutical giant presented mid-stage trial data on the pill, muvalaplin, at the American Heart Association Scientific ...
Earlier on Wednesday, Laekna, “a global biotech company focused on novel drug development for metabolic and cancer diseases,” accoding to its ...
Eli Lilly and Company (NYSE: LLY) announced today that it has elected Jon Moeller as a new member of its board of directors ...
The makers of Ozempic and Zepbound are fighting to stop compounded copies of their drugs. But it’s unclear whether they can ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback